Expression of Fas(APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2078-2080

  Cardi, Gaetano ^b,c   Heaney, John A ^a   Schned, Alan R ^a   Ernstoff, Marc S ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPHOCYTIC INFILTRATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ANTIGENS, CD95; ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING;

EID: 0032523943     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lynch, D. H., Ramsdell, F., and Alderson, M. R. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today, 16: 569-574, 1995.
2. Lenardo, M. J. Fas and the art of lymphocyte maintenance. J. Exp. Med., 183: 721-724, 1996.
3. Russell, J. H. Activation-induced death of mature T cells in the regulation on immune response. Curr. Opin. Immunol., 7: 382-388, 1995.
4. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., and Ferguson, T. A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science (Washington DC), 270: 1189-1192, 1995.
5. Xerri, L., Devilard, E., Hassoun, J., Mawas, C., and Birg, F. Fas ligand is not only expressed in immune privileged human organs but also is coexpressed with Fas in various epithelial tissues. Mol. Pathol., 50: 87-91, 1997.
6. Oshimi, Y., Oda, S., Honda, Y., Nagata, S., and Miyazaki, S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol., 157: 2909-2915, 1996.
7. Vignaux, F., Vivier, E., Malissen, B., Depraetere, V., Nagata, S., and Golstein, P. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med., 181: 781-786, 1995.
8. O'Connell, J., O'Sullivan, G. C., Collins, J. K., and Shanahan, F. The Fas counter-attack: fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med., 184: 1075-1082, 1996.
9. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J. C., and Tschopp, J. Melanoma cell expression of Fas(APO-1/CD95)-ligand: implication for tumor immuno escape. Science (Washington DC), 274: 1363-1366, 1996.
10. Williams, N. Tumor cells fight back to beat immune system. Science (Washington DC), 274: 1302, 1996.
11. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F., and Lynch, D. H. Fas ligand mediates activation-induced cell death in human lymphocytes. J. Exp. Med., 181: 71-77, 1995.
12. Ettinger, R., Panka, D. J., Wang, J. K., Stanger, B. Z., Ju, S. T., and Marshak-Rothstein, A. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen. J. Immunol., 154: 302-4308, 1995.
13. Oberg, H. H., Lengl-Janssen, B., Kabelitz, D., and Janssen, O. Activation-induced T cell death: resistance or susceptibility correlate with cell surface Fas ligand and T helper Lymphocytes expression. Cell. Immunol., 181: 93-100, 1997.
14. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothstein, A. Fas(CD95)FasL interactions required for programmed cell death alter T-cell activation. Nature (Lond.), 373: 385-386, 1995.
15. Niehans, G. A., Brunner, T., Frizelle, S. P., Liston, J. C., Salerno, C. T., Knapp, D. J., Green, D. R., and Kratzke, R. A. Human lung carcinomas express Fas ligand. Cancer Res., 57: 1007-1012, 1997.
16. Walker, P. R., Saas, P., and Dietrich, P. Y. Role of Fas ligand (CD95L) in immune escape the tumor cells strike back. J. Immunol., 158: 4521-4524, 1997.
17. Cardi, G., Heany, J. A., Schned, A. R., Phillips, D. M., Branda, M. T., and Ernstoff, M. S. T-cell receptor (ζ-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma. Cancer Res., 57: 3517-3519, 1997.
18. Cardi, G., Mastrangelo, M. J., and Berd, D. Depletion of CD4+CD45R+ phenotype in lymphocytes that infiltrate subcutaneous metastases of human melanoma. Cancer Res., 49: 6562-6565, 1989.
19. Zheng, L., Fisher, G., Miller, E. R., Peschon, J., Lynch, H. D., and Lenardo, M. J. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature (Lond.), 377: 348-351, 1995.
20. Akbar, A. N., and Salmon, M. Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol. Today, 18: 72-76, 1997.
21. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H., and Nagata, S. Fas ligand in human serum. Nat. Med., 2: 317-322, 1996.